Cargando…
Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy
Bacterial outer membrane vesicles (OMVs) are potent immuno-stimulating agents and have the potentials to be bioengineered as platforms for antitumor nanomedicine. In this study, OMVs are demonstrated as promising antitumor therapeutics. OMVs can lead to beneficial M2-to-M1 polarization of macrophage...
Autores principales: | Li, Yongjiang, Wu, Junyong, Qiu, Xiaohan, Dong, Suhe, He, Jun, Liu, Jihua, Xu, Wenjie, Huang, Si, Hu, Xiongbin, Xiang, Da-Xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253654/ https://www.ncbi.nlm.nih.gov/pubmed/35846843 http://dx.doi.org/10.1016/j.bioactmat.2022.05.037 |
Ejemplares similares
-
Extracellular vesicles derived from different sources of mesenchymal stem cells: therapeutic effects and translational potential
por: Cai, Jiaxin, et al.
Publicado: (2020) -
Exploiting metabolic inhibition to eradicate residual tumors after chemo-immunotherapy
por: Habtetsion, Tsadik, et al.
Publicado: (2014) -
Outer membrane vesicles as platform vaccine technology
por: van der Pol, Leo, et al.
Publicado: (2015) -
Outer Membrane Vesicles: An Emerging Vaccine Platform
por: Kashyap, Dharmendra, et al.
Publicado: (2022) -
Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies
por: Zhou, Min, et al.
Publicado: (2023)